Moreover, owing to its ability to produce PI(3,4)P2, SHIP2 can actually promote Akt activation, and SHIP2 inhibition can kill breast and colon cancer cells; thus, SHIP2 may function as an oncogene as well [59, 60]. This evidence concerns the gene INPPL1 and malignant colon neoplasm.